Patents by Inventor Ian Bathurst

Ian Bathurst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070105768
    Abstract: A dry powder composition comprises recombinant human alpha 1-antitrypsin (rAAAT).
    Type: Application
    Filed: November 10, 2004
    Publication date: May 10, 2007
    Inventors: Rajiv Nayar, Mark Manning, Philip Barr, Philip Pemberton, Ian Bathurst, Helen Gibson
  • Publication number: 20060063738
    Abstract: The present invention provides therapeutic compositions containing lysophosphatidic acids, methods for making the compositions, and methods of use thereof.
    Type: Application
    Filed: September 26, 2005
    Publication date: March 23, 2006
    Applicant: Sky High, LLC
    Inventors: Ian Bathurst, Matthew Foehr, J. Goddard, Samuil Umansky, John Bradley, Donald Picker
  • Patent number: 6321909
    Abstract: A composition comprising a storage-stable organ preservation solution, comprising a linear polyethylene glycol having an average molecular weight of approximately 20,000 Daltons and being essentially free of decomposition products. This solution can be used for organ preservation as a perfusate in a process in which the perfusate is flowed through the circulatory system of the organ, and can also be used for transplantation or routine open heart cardioplegic applications. The composition can be contained in a system comprising a means for preventing light exposure, especially UV light, to the solution. In addition, the system is preferably impervious to gases, particularly oxygen.
    Type: Grant
    Filed: February 12, 1998
    Date of Patent: November 27, 2001
    Assignee: Sky High, LLC
    Inventors: Winston Wicomb, Geoffrey Collins, Ian Bathurst, Matthew Foehr
  • Publication number: 20010037956
    Abstract: A composition comprising a storage-stable organ preservation solution, comprising a linear polyethylene glycol having an average molecular weight of approximately 20,000 Daltons and being essentially free of decomposition products. This solution can be used for organ preservation as a perfusate in a process in which the perfusate is flowed through the circulatory system of the organ, and can also be used for transplantation or routine open heart cardioplegic applications.
    Type: Application
    Filed: February 12, 1998
    Publication date: November 8, 2001
    Inventors: WINSTON WICOMB, GEOFFREY COLLINS, IAN BATHURST, MATTHEW FOEHR